个体疗效求差异抗血小板药物临床医疗新选择
个体疗效求差异抗血小板药物临床医疗新选择: 【慧聪制药工业网】近日，替格瑞洛经由国家食品药品监督管理局（SFDA）审批，获取进口药品许可证（IDL）在中国市场上市，这意味着抗血小板药物在临床治疗中增添了一个新的选择，同时也能弥补现有药物个体 ...
Chinese spend more on diapers and Colgate despite economic woes
... economy. China's economic slump after the pandemic has weighed on sales at consumer packaged goods companies, who had targeted the world's second ... View article...